Investigation Overview
October 21, 2013 (Shareholders Foundation) - An investigation on behalf of investors of Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPR) shares over potential securities laws violations by Catalyst Pharmaceutical Partners, Inc. and certain of its directors and officers in connection certain statements over its drug Firdapse was announced. The investigation by a law firm focuses on...
You must register (for free) or login to view the entire investigation.